Product News: Siemens Launches New Point-of-Care Cardiac Analyzer at Arab Health 2015
29 Jan 2015
The Diagnostics Division of Siemens Healthcare is unveiling its latest point-of-care acute care analyzer for the management of patients with cardiovascular disease symptoms at Medlab in Arab Health 2015, Dubai, January 26-29. The company’s Stratus CS 200 Acute Care Diagnostic System1
is designed to enhance simple operation and instrument management at the point of care to help facilitate rapid decision making and optimal patient care.
The new Stratus CS 200 system has a user-friendly, touch screen interface that makes it easy to navigate through menus. A barcode reader eliminates the need for manual entry and reduces potential for error. The system also offers bi-directional connectivity, which allows for safe and secure results transmission with third-party data managers, and provides capability for remote operator lock-out and monitoring of calibration dates. In addition, the Stratus CS 200 system automatically spins whole blood into plasma for testing, reducing the risk of biohazard exposure and ensures results will be comparable to lab tests run on plasma samples.
The Stratus CS 200 system delivers a robust cardiac assay menu, including high-sensitivity Troponin I.2
First results are available in as fast as 14 minutes, and subsequent results available in as little as four minutes.
Cardiovascular diseases (CVDs) are the number one cause of death globally. According to the World Health Organization (WHO), in 2008, an estimated 17.3 million people died from CVDs, representing 30 percent of all global deaths. This number is expected to grow to 25 million by 2030.3
For patients with CVD, it’s critical that their acute care be timely, safe and effective.
“When a patient presents with chest pain in the emergency department, clinicians are challenged to quickly determine the cause and chart an appropriate course of treatment,” said David Stein, PhD, CEO, Point of Care Business Unit, Diagnostics Division, Siemens Healthcare. “The Stratus CS 200 system delivers fast, reliable results at the point of care, allowing physicians to make a timely diagnosis and quickly determine an appropriate treatment plan.”
1. Not available for sale in the U.S. Product availability varies by country.
2. High sensitivity CTNI is defined as an imprecision level of 10% at the 99th percentile of normal population by the joint ESC/ACC committee.
3. World Health Organization. Cardiovascular diseases. http://www.who.int/mediacentre/factsheets/fs317/en/index.html. Accessed 10/15/12